Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PSTV – Plus Therapeutics Inc

PLUS THERAPEUTICS, Inc.
PSTV
$5.50
Name : PLUS THERAPEUTICS, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $37,861,432.00
EPSttm : 21.56
finviz dynamic chart for PSTV
PLUS THERAPEUTICS, Inc.
$5.50
0.54%
$0.03
PSTV — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

16.99

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.2

EPS Last/This Y

3.38

EPS This/Next Y

1.5

Price

5.59

Target Price

36

Analyst Recom

1

Performance Q

-27.27

Upside

-2,180.9%

Beta

1.36

Ticker: PSTV




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11PSTV6.06N/AN/A0
2026-05-12PSTV5.85N/AN/A0
2026-05-13PSTV5.72N/AN/A0
2026-05-14PSTV5.77N/AN/A0
2026-05-15PSTV5.25N/AN/A0
2026-05-18PSTV5.85N/AN/A0
2026-05-19PSTV5.83N/AN/A0
2026-05-20PSTV6.45N/AN/A0
2026-05-21PSTV6.82N/AN/A0
2026-05-22PSTV6.7N/AN/A0
2026-05-26PSTV6.66N/AN/A0
2026-05-27PSTV6.73N/AN/A0
2026-05-28PSTV6.44N/AN/A0
2026-05-29PSTV5.93N/AN/A0
2026-06-02PSTV5.5N/AN/A0
2026-06-03PSTV5.34N/AN/A0
2026-06-04PSTV5.74N/AN/A0
2026-06-05PSTV5.45N/AN/A0
2026-06-08PSTV5.56N/AN/A0
2026-06-09PSTV5.59N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11PSTV6.0393.9- -3.82
2026-05-12PSTV5.8493.9- -3.82
2026-05-13PSTV5.7293.9- -3.82
2026-05-14PSTV5.7693.9- -3.82
2026-05-15PSTV5.2593.9- -3.82
2026-05-18PSTV5.8693.9- -3.82
2026-05-19PSTV5.7793.9- -3.82
2026-05-20PSTV6.4093.9- -3.82
2026-05-21PSTV6.7993.9- -3.82
2026-05-22PSTV6.62-464.6- -4.78
2026-05-26PSTV6.71-435.4- -3.87
2026-05-27PSTV6.73-435.4- -3.87
2026-05-28PSTV6.44-435.4- -3.87
2026-05-29PSTV5.89-435.4- -3.87
2026-06-01PSTV5.77-100.0- -3.87
2026-06-02PSTV5.48-100.0- -3.87
2026-06-03PSTV5.39-100.0- -3.87
2026-06-04PSTV5.78-100.0- -3.87
2026-06-05PSTV5.38-100.0- -3.87
2026-06-08PSTV5.56-100.0- -3.87
2026-06-09PSTV5.59-100.0- -3.87
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11PSTV0.004.2119.77
2026-05-12PSTV0.004.2118.08
2026-05-13PSTV0.004.2118.08
2026-05-14PSTV0.004.2118.08
2026-05-15PSTV0.004.2118.08
2026-05-18PSTV0.004.1918.08
2026-05-19PSTV0.004.1918.08
2026-05-20PSTV0.004.1918.03
2026-05-21PSTV0.004.1918.03
2026-05-22PSTV0.004.1918.03
2026-05-26PSTV0.00-1.4718.03
2026-05-27PSTV0.00-1.4718.03
2026-05-28PSTV0.00-1.4716.99
2026-05-29PSTV0.00-1.4716.99
2026-06-02PSTV0.00-1.9416.99
2026-06-03PSTV0.00-1.9416.99
2026-06-04PSTV0.00-1.9416.99
2026-06-05PSTV0.00-1.9416.99
2026-06-08PSTV0.00-1.9416.99
2026-06-09PSTV0.00-1.9416.99
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-1.05

Avg. EPS Est. Current Quarter

-0.87

Avg. EPS Est. Next Quarter

-0.85

Insider Transactions

Institutional Transactions

-1.94

Beta

1.36

Average Sales Estimate Current Quarter

1

Average Sales Estimate Next Quarter

1

Fair Value

Quality Score

15

Growth Score

22

Sentiment Score

23

Actual DrawDown %

99.5

Max Drawdown 5-Year %

-99.7

Target Price

36

P/E

Forward P/E

PEG

P/S

7.31

P/B

2.56

P/Free Cash Flow

EPS

-3.27

Average EPS Est. Cur. Y​

-3.87

EPS Next Y. (Est.)

-2.37

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-306.66

Relative Volume

0.35

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

-3.87

EBIT Estimation

PSTV Healthcare
$5.50
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
12/20
Pullback
18/25
Volume
11/15
Valuation
12/20
TP/AR
6/10
Options
0/10
RSI
43.8
Range 1M
15.1%
Sup Dist
4.7%
🚀
Momentum Growth
Ride accelerating trends
N/A
31 /100
WEAK
Momentum
5/25
Growth
20/30
Estimates
6/20
Inst/Vol
0/15
Options
0/10
EPS Yr
45.9%
EPS NY
38.9%
52W%
12.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +554.5% upside
Quality
6/30
Valuation
16/30
Growth
17/25
Stability
6/10
LT Trend
4/5
Upside
+554.5%
Quality
15
PLUS THERAPEUTICS, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 28
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary liver cancers by intra-arterial injection. In addition, it develops and commercializes laboratory-developed tests comprising the CNSide Test to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Houston, Texas.
PSTV

Latest News

Caricamento notizie per PSTV
stock quote shares PSTV – Plus Therapeutics Inc Stock Price stock today
news today PSTV – Plus Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PSTV – Plus Therapeutics Inc yahoo finance google finance
stock history PSTV – Plus Therapeutics Inc invest stock market
stock prices PSTV premarket after hours
ticker PSTV fair value insiders trading